Kevin Buckley

Shareholder Kevin Buckley

kevin@torreypineslaw.com
+1 (858) 800-2537 x702

Kevin Buckley is an experienced transactional, intellectual property, and regulatory attorney for high technology businesses. His clients include biotechnology, pharmaceutical, specialty chemical, medical device, digital health, diagnostics, and convergence technology businesses. The "convergence" often includes machine learning, artificial intelligence, and complex algorithms. He has served in leadership positions in large law firms and has managed longstanding relationships with clients including multi-national corporations, private research institutes, and the nation's premier public university system.

Prior to founding Torrey Pines Law Group, he managed all legal affairs for the research function of the second-largest American university well-known for developing medical, laser, optics, and simulation technologies. He also advised the board of a private research foundation with respect to complex corporate governance matters. For many years, he was recognized nationally for his law practice by The Best Lawyers in America.

Areas of focus include intellectual property, transactional, and regulatory counseling; international patent preparation and prosecution; corporate and commercial transactions; technology transfer; technology licensing; transactional due diligence; legal opinion drafting; litigation avoidance; and IP infringement litigation. He has assisted clients with private investments totaling nearly $100 Million and with transactions totaling over $1 Billion.

Prior to becoming an attorney, he was a biochemist and small business owner. He has also been an academic advisor to entrepreneurship centers at the University of Pennsylvania and Washington University in St. Louis. He was also an adjunct professor at Washington University School of Law where he taught a Biotechnology Law intersession course.

Kevin received a Bachelor of Science in Biochemistry from UC San Diego where he was an undergraduate Research Scholar. He then received a Juris Doctor from the University of Pittsburgh School of Law where he was Editor-in-Chief of the Pittsburgh Journal of Technology Law and Policy.

Distinctions

Kevin has been selected by his peers for inclusion in:

  • The Best Lawyers in America
  • Philadelphia's Best Lawyers
  • SuperLawyers Rising Star
  • St. Louis Magazine Best Lawyers
  • St. Louis Business Journal "Who's Who in Technology"
  • St. Louis Business Journal "40 Under Forty"

Selected Speaking Engagements

  • Presenter, Legal, Financial and Tax Strategies for Start-Ups, Sanford Consortium for Regenerative Medicine, San Diego, CA (January 28, 2015)
  • PresenterIP Strategy Informed by the Commercialization Process, Pennsylvania Bio Inaugural Knowledge Fair, Valley Forge, PA (June 8, 2011)
  • Guest LecturerEntrepreneurial Investing - Management 424/524, Washington University Olin Business School, St. Louis, MO (October 13, 2009 and March 2, 2010)
  • Adjunct Professor Biotechnology Law From Patents to Food-Drug-Planting Approvals (Intersession Course) - Washington University School of Law, St. Louis, MO (January 11-15, 2010)
  • Co-Presenter (Fully-Accredited Continuing Legal Education), In re '318 Patent Infringement Litigation - Better to be Smart than Lucky: The Problems of Obtaining a Patent for Guessing Right, Monsanto Company (December 7, 2009)
  • PanelistBringing Overseas Start-Ups Into the U.S. Inaugural Global Healthcare Investing Conference, Cleveland, OH (June 20, 2007)

Jurisdictions

Kevin is registered to practice before the U.S. Patent & Trademark Office, and admitted to practice law in Missouri and Pennsylvania. He is also admitted to the Federal Circuit Court of Appeals.